References

Bamigboye, A.A., G.J. Hofmeyr and D.A. Merrell, 1987. Rectal misoprostol in the prevention of postpartum hemorrhage: A placebo-controlled trial. Am. J. Obstet. Gynecol., 179: 1043-1046.
PubMed  |  

Choo, W.L., S. Chua, Y.S. Chong, K. Vanaja and P.L. Oei et al., 1998. Correlation of change in uterine activity to blood loss in the third stage of labour. Gynecol. Obstet. Invest., 46: 178-180.
PubMed  |  

El-Refaey, H., P. O'Brien, W. Morafa, J. Walder and C. Rodeck, 1997. Use of oral misoprostol in the prevention of postpartum haemorrhage. Br. J. Obstet. Gynaecol., 104: 336-339.
PubMed  |  

Hofmeyr, G.J., V.C. Nikodem, M. de Jager and B.R. Gelbart, 1998. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br. J. Obstet. Gynaecol., 105: 971-975.
PubMed  |  

Karim, A., 1987. Antiulcer prostaglandin misoprostol: Single and multiple dose pharmacokinetic profile. Prostaglandins, 33: 40-50.
PubMed  |  

Kundodyiwa, T.W., F. Majoko and S. Rusakaniko, 2001. Misoprostol versus oxytocin in the third stage of labor. Int. J. Gynaecol. Obstet., 75: 235-241.
PubMed  |  

Prendiville, W., D. Elbourne and I. Chalmers, 1988. The effects of routine oxytocic administration in the management of the third stage of labour: An overview of the evidence from controlled trials. Br. J. Obstetr. Gynaecol., 95: 3-16.
CrossRef  |  PubMed  |  Direct Link  |  

Toppozada, M., M. El-Bossaty, H.A. El-Rahman and A.H. El-Din, 1981. Control of intractable atonic postpartum hemorrhage by 15-methyl prostaglandin F2 alpha. Obstet. Gynecol., 58: 327-330.
PubMed  |  

Widmer, M., J. Blum, G.J. Hofmeyr, G. Carroli and H. Abdel-Aleem et al., 2010. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: A multicentre, double-blind randomised trial. Lancet, 375: 1808-1813.
CrossRef  |